Found 6 matching trials
Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer PHASE3 The purpose of the study is to assess the efficacy and safety of BAY1841788...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers PHASE2 This Investigator-initiated, Treatment of High-Risk Prostate Cancer Guided ...
Show More Location
ZAS Sint-Augustinus
Learn More & Join Trial
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies PHASE3 Researchers are looking for a better way to treat men at high-risk of bioch...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital - Phoenix - Cardiology
Learn More & Join Trial
Imaging Study to Compare Effects of Darolutamide and Enzalutamide With Respect to Placebo on the Blood Flow in the Brain in Healthy Male Volunteers. PHASE1 The current study would investigate the effects of a single dose of darolut...
Show More Location
Centre for Neuroimaging Sciences, King's College
Learn More & Join Trial
Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer PHASE3 The purpose of this study is to assess the safety and efficacy of BAY184178...
Show More Location
Multiple Locations
Learn More & Join Trial
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer PHASE3 The purpose of the study is to assess the efficacy and safety of darolutami...
Show More Learn More & Join Trial